Item 2. Properties
ITEM
2. PROPERTIES
Our
corporate headquarters are located in Warren, New Jersey, and consist of 6,708 square feet dedicated to corporate, operational, and pre-commercial
activities under a lease that expires February 14, 2026. We also have two research and development facilities located in Philadelphia:
our 3,620 square foot research and development center under a lease that expires June 30, 2025; and a shared facility with laboratory
space dedicated to us that is focused on preclinical and pharmacodynamic activities.
ITEM
3. LEGAL PROCEEDINGS
From
time to time, we have been and may be involved in legal proceedings. There are no material pending legal proceedings to which we are
party or to which any of our property is subject.
ITEM
4. MINE SAFETY DISCLOSURES
Not
applicable.
78
PART
II
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.